Status:
COMPLETED
Transdermal Neuromodulation for Management of Chronic Pelvic Pain in Women
Lead Sponsor:
Kafrelsheikh University
Conditions:
Pelvic Pain Syndrome
Eligibility:
FEMALE
20-30 years
Phase:
NA
Brief Summary
Background: Chronic pelvic pain (CPP) significantly impacts the quality of life in women. This study investigated the effects of transdermal neuromodulation in females with CPP. Trial Design: Paralle...
Eligibility Criteria
Inclusion
- nulliparous, with a body mass index not exceeding 30 kg/m2 and complaining of idiopathic chronic pelvic pain syndrome (CPP).
Exclusion
- chronic uterine prolapse, endometriosis, pelvic tumor, any sexual problems, an active genitourinary infection, heart diseases, kidney diseases, cognitive disorders or any physical or psychological condition that might impair the ability to provide written informed consent or adhere to the research procedure
Key Trial Info
Start Date :
August 1 2023
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
November 30 2023
Estimated Enrollment :
35 Patients enrolled
Trial Details
Trial ID
NCT06080828
Start Date
August 1 2023
End Date
November 30 2023
Last Update
March 25 2024
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Kafrelshaikh University
Kafr ash Shaykh, Egypt, 12623